(Q40598902)

21 September 2017

Second malignant neoplasms after treatment of childhood cancer (English)

1 reference

21 September 2017

1 reference

Klein G

1

1 reference

21 September 2017

Michaelis J

2

1 reference

21 September 2017

Spix C

3

1 reference

21 September 2017

Wibbing R

4

1 reference

21 September 2017

Eggers G

5

1 reference

21 September 2017

Ritter J

6

1 reference

21 September 2017

Kaatsch P

7

1 reference

21 September 2017

1 April 2003

1 reference

European Journal of Cancer

21 September 2017

1 reference

21 September 2017

39

1 reference

21 September 2017

6

1 reference

21 September 2017

808-817

1 reference

Leukemia after therapy with alkylating agents for childhood cancer

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Breast cancer and other second neoplasms after childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Thyroid cancer after radiotherapy for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Childhood malignancies in Germany--methods and results of a nationwide registry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Multiple primary neoplasms in childhood: data from the German Children's Cancer Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Population-based epidemiologic data on brain tumors in German children

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Can protocol-specified doses of chemotherapy and radiotherapy be used as a measure of treatment actually received? A CCG/NIH study on long-term survivors of acute lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

High incidence of secondary brain tumours after radiotherapy and antimetabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900875-4

7 January 2021

10.1016/S0959-8049(02)00875-4

Identifiers

DOI

1 reference

21 September 2017

1 reference